Implanet entered into a distribution agreement with Aegis Spine, subsidiary of South Korea-based L&K Biomed, to complement Implanet’s commercialization activity in the U.S. First procedures with Aegis Spine’s surgeons are slated for February 2018.
Implanet and L&K entered a preliminary distribution agreement in December 2017. While global in scope, that agreement includes a particular focus on the U.S. and Asia. This and other agreements support Implanet’s expansion of its spine and knee products globally.
Implanet entered into a distribution agreement with Aegis Spine, subsidiary of South Korea-based L&K Biomed, to complement Implanet's commercialization activity in the U.S. First procedures with Aegis Spine's surgeons are slated for February 2018.
Implanet and L&K entered a preliminary distribution agreement in December 2017. While...
Implanet entered into a distribution agreement with Aegis Spine, subsidiary of South Korea-based L&K Biomed, to complement Implanet’s commercialization activity in the U.S. First procedures with Aegis Spine’s surgeons are slated for February 2018.
Implanet and L&K entered a preliminary distribution agreement in December 2017. While global in scope, that agreement includes a particular focus on the U.S. and Asia. This and other agreements support Implanet’s expansion of its spine and knee products globally.
Copy to clipboard 
